Effects of sleeve gastrectomy and medical treatment for obesity on glucagon-like peptide 1 levels and glucose homeostasis in non-diabetic subjects

Obesity Surgery

Volumn 21, Issue 7, 2011, Pages 902-909

  Valderas, Juan Patricio ^a   Irribarra, Veronica ^a   Rubio, Lorena ^a   Boza, Camilo ^a   Escalona, Manuel ^a   Liberona, Yessica ^a   Matamala, Andrea ^a   Maiz, Alberto ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Diet; Glucagon like peptide 1; Insulin secretion; Insulin resistance; Obesity; Sleeve gastrectomy; Surgery for obesity; Weight loss

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN;

ADULT; AEROBIC EXERCISE; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CALORIC RESTRICTION; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FLUID INTAKE; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN SENSITIVITY; OBESITY; POSTOPERATIVE PERIOD; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESISTANCE TRAINING; SLEEVE GASTRECTOMY; TREATMENT OUTCOME; WEIGHT REDUCTION;

ADULT; BLOOD GLUCOSE; DIET, REDUCING; EXERCISE THERAPY; FEMALE; GASTRECTOMY; GLUCAGON-LIKE PEPTIDE 1; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; PROSPECTIVE STUDIES; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 79960250910     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-011-0375-4     Document Type: Article

References (39)

1. T Kelly W Yang CS Chen, et al. 2008 Global burden of obesity in 2005 and projections to 2030 Int J Obes 32 1431 7 10.1038/ijo.2008.102 1:STN:280:DC%2BD1cngsVamtQ%3D%3D
2. JB Dixon 2010 The effect of obesity on health outcomes Mol Cell Endocrinol 316 104 8 19628019 10.1016/j.mce.2009.07.008 1:CAS:528: DC%2BD1MXhs1WgtbnM
3. RA DeFronzo 2010 Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links Diabetologia 53 1270 87 20361178 10.1007/s00125-010-1684-1 1:CAS:528:DC%2BC3cXmsFyrs7w%3D
4. A Avenell TJ Brown MA McGee, et al. 2004 What are the long-term benefits of weight reducing diets in adults? A systematic review of randomized controlled trials J Hum Nutr Diet 17 317 35 15250842 10.1111/j.1365-277X.2004.00531.x 1:STN:280:DC%2BD2czkvV2jtg%3D%3D (Pubitemid 39136775)
5. MJ Franz JJ VanWormer AL Crain, et al. 2007 Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up J Am Diet Assoc 107 1755 67 17904936 10.1016/j.jada.2007.07.017 (Pubitemid 47464109)
6. H Buchwald R Estok K Fahrbach, et al. 2009 Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis Am J Med 122 248 56 19272486 10.1016/j.amjmed.2008.09.041
7. RD Bloomberg A Fleishman JE Nalle, et al. 2005 Nutritional deficiencies following bariatric surgery: what have we learned? Obes Surg 15 145 54 15802055 10.1381/0960892053268264 (Pubitemid 40315996)
8. M Gagner M Deitel TL Kalberer, et al. 2009 The Second International Consensus Summit for sleeve gastrectomy, March 19-21, 2009 Surg Obes Relat Dis 5 476 85 19632647 10.1016/j.soard.2009.06.001
9. R Peterli B Wölnerhanssen T Peters, et al. 2009 Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial Ann Surg 250 234 41 19638921 10.1097/SLA.0b013e3181ae32e3
10. JJ Holst 2007 The physiology of glucagon-like peptide 1 Physiol Rev 87 1409 39 17928588 10.1152/physrev.00034.2006 1:CAS:528:DC%2BD2sXhtlaqu7jI (Pubitemid 350041474)
11. CF Deacon JJ Holst 2009 Immunoassays for the incretin hormones GIP and GLP-1 Best Pract Res Clin Endocrinol Metab 23 425 32 19748060 10.1016/j.beem.2009.03.006 1:CAS:528:DC%2BD1MXhtFajt77M
12. MA Nauck 2009 Unraveling the science of incretin biology Am J Med 122 S3 10 19464426 10.1016/j.amjmed.2009.03.012
13. M Bose B Oliván J Teixeira, et al. 2009 Do incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: what are the evidence? Obes Surg 19 217 29 18820978 10.1007/s11695-008-9696-3
14. JP Valderas V Irribarra C Boza, et al. 2010 Medical and surgical treatments for obesity have opposite effects on peptide YY and appetite: a prospective study controlled for weight loss J Clin Endocrinol Metab 95 1069 75 20097707 10.1210/jc.2009-0983 1:CAS:528:DC%2BC3cXjs1Kqsb0%3D
15. J van Delft O Uttenthal C Koch, et al. 1999 Immunoblockade of endogenous glucagon-like peptide-1 by monoclonal antibodies in conscious rats: effect on the insulin response to intragastric glucose Metabolism 48 41 6 9920143 10.1016/S0026-0495(99)90008-2 (Pubitemid 29035559)
16. DR Matthews JP Hosker AS Rudenski, et al. 1985 Homeostasis model assessment: insulin resistence and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 412 9 3899825 10.1007/BF00280883 1:CAS:528:DyaL2MXlslKnu7k%3D (Pubitemid 15018832)
17. M Matsuda RA DeFronzo 1999 Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp Diab Care 22 1462 70 10.2337/diacare.22.9.1462 1:STN:280:DyaK1MvgvVertQ%3D%3D (Pubitemid 29418240)
18. M Stumvoll A Mitrakou W Pimenta, et al. 2000 Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity Diab Care 23 295 301 10.2337/diacare.23.3.295 1:CAS:528:DC%2BD3cXjt1Ckuro%3D (Pubitemid 30131733)
19. F Bacha N Gungor SA Arslanian 2008 Measures of beta-cell function during the oral glucose tolerance test, liquid mixed-meal test, and hyperglycemic clamp test J Pediatr 152 618 21 18410762 10.1016/j.jpeds.2007.11.044 1:CAS:528:DC%2BD1cXks1ars7o%3D
20. KC Maki JM McKenney MV Farmer, et al. 2009 Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose Nutr J 28 1 10
21. SD Navaneethan KR Kelly F Sabbagh, et al. 2010 Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery Obes Surg 20 308 15 20217955 10.1007/s11695-009-0026-1
22. E Ferrannini S Camastra A Gastaldelli, et al. 2004 Beta-cell function in obesity: effects of weight loss Diabetes 53 S26 33 15561918 10.2337/diabetes.53. suppl-3.S26 1:CAS:528:DC%2BD2cXhtVOls7zL
23. JA Pereira BM Claro JC Pareja, et al. 2003 Restored insulin inhibition on insulin secretion in nondiabetic severely obese patients after weight loss induced by bariatric surgery Int J Obes Relat Metab Disord 27 463 8 12698955 10.1038/sj.ijo.0802269 1:CAS:528:DC%2BD3sXitl2htr0%3D (Pubitemid 36520845)
24. J Jimenez S Zuniga-Guajardo B Zinman, et al. 1987 Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity J Clin Endocrinol Metab 64 661 8 3546350 10.1210/jcem-64-4-661 1:CAS:528:DyaL2sXitFajsr8%3D (Pubitemid 17044529)
25. MR Letiexhe AJ Scheen, et al. 1994 Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects Int J Obes Relat Metab Disord 18 295 300 8061722 1:STN:280:DyaK2czjvF2ksA%3D%3D (Pubitemid 24140807)
26. R Morínigo AM Lacy R Casamitjana, et al. 2006 GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects Obes Surg 16 1594 601 17217635 10.1381/096089206779319338 (Pubitemid 46032812)
27. S Camastra M Manco A Mari, et al. 2005 Beta-cell function in morbidly obese subjects during free living: long-term effects of weight loss Diabetes 54 2382 9 16046305 10.2337/diabetes.54.8.2382 1:CAS:528:DC%2BD2MXnt1yntrk%3D (Pubitemid 41134266)
28. B Laferrère S Heshka K Wang, et al. 2007 Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes Diab Care 30 1709 16 10.2337/dc06-1549 (Pubitemid 47036341)
29. M Horowitz DJ Cook PJ Collins, et al. 1982 Measurement of gastric emptying after gastric bypass surgery using radionuclides Br J Surg 69 655 7 7127049 10.1002/bjs.1800691108 1:STN:280:DyaL3s%2Fitl2msA%3D%3D (Pubitemid 13232187)
30. J Melissas S Koukouraki J Askoxylakis, et al. 2007 Sleeve gastrectomy: a restrictive procedure? Obes Surg 17 57 62 17355769 10.1007/s11695-007-9006-5
31. MA Nauck U Niedereichholz R Ettler, et al. 1997 Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans Am J Physiol 273 E981 8 9374685 1:CAS:528:DyaK2sXnsFams70%3D
32. FB Langer MA Reza Hoda, et al. 2005 Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels Obes Surg 15 1024 9 16105401 10.1381/0960892054621125 1:STN:280:DC%2BD2MvjvFerug%3D%3D (Pubitemid 41116888)
33. F Broglio E Arvat A Benso, et al. 2001 Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans J Clin Endocrinol Metab 86 5083 6 11600590 10.1210/jc.86.10.5083 1:CAS:528:DC%2BD3MXptVartb0%3D (Pubitemid 33020569)
34. J Tong RL Prigeon HW Davis, et al. 2010 Ghrelin suppresses glucose-stimulated insulin secretion and deteriorates glucose tolerance in healthy humans Diabetes 59 2145 51 20584998 10.2337/db10-0504 1:CAS:528:DC%2BC3cXht12kurbP
35. M Guldstrand B Ahrén E Näslund, et al. 2009 Dissociated incretin response to oral glucose at 1 year after restrictive vs. malabsorptive bariatric surgery Diabetes Obes Metab 1 1027 33 10.1111/j.1463-1326.2009.01089.x
36. JJ Meier MA Nauck A Pott, et al. 2006 Glucagon-like peptide 2 stimulates glucagon secretion, enhances lipid absorption, and inhibits gastric acid secretion in humans Gastroenterology 130 44 54 16401467 10.1053/j.gastro.2005. 10.004 1:CAS:528:DC%2BD28XhtFCgtbw%3D (Pubitemid 43049834)
37. M Christensen FK Knop T Vilsbøll, et al. 2010 Glucagon-like peptide-2, but not glucose-dependent insulinotropic polypeptide, stimulates glucagon release in patients with type 1 diabetes Regul Pept 163 96 101 20580750 10.1016/j.regpep.2010.05.004 1:CAS:528:DC%2BC3cXotVCnu70%3D
38. L Hansen JJ Holst 2002 The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum. A duodeno-ileal loop? Regul Pept 110 39 45 12468108 10.1016/S0167-0115(02)00157-X 1:CAS:528:DC%2BD38XptFelt78%3D (Pubitemid 35435331)
39. C Orskov JJ Holst 1987 Radio-immunoassays for glucagon-like peptides 1 and 2 (GLP-1 and GLP-2) Scand J Clin Lab Invest 47 165 74 3576119 1:STN:280:DyaL2s3gs1Shuw%3D%3D (Pubitemid 17050199)